HST Global, Inc. (HSTC)
OTCMKTS · Delayed Price · Currency is USD
0.6250
0.00 (0.00%)
At close: Mar 19, 2026
HST Global Market Cap
HST Global has a market cap or net worth of $88.4 million as of March 26, 2026. Its market cap has increased by 16,741.70% in one year.
Market Cap
88.40M
Enterprise Value
88.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.63
Market Cap Chart
Since May 12, 2008, HST Global's market cap has increased from 11.89M to 88.40M, an increase of 643.70%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 88.40M | -32.89% |
| Dec 9, 2025 | 131.71M | 224.37% |
| Dec 30, 2024 | 40.61M | 1,173.50% |
| Dec 26, 2023 | 3.19M | 406.25% |
| Dec 30, 2022 | 629.83K | 9.09% |
| Dec 21, 2021 | 577.34K | 88.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 333.33M |
| Silence Therapeutics | 245.62M |
| Vaxart | 167.00M |
| BioStem Technologies | 86.14M |
| Nuo Therapeutics | 65.67M |
| Vicapsys Life Sciences | 48.56M |
| Anebulo Pharmaceuticals | 42.01M |
| Cell Source | 37.29M |